Gilead Sciences, Inc. (GILD)
146.76
+0.64
(+0.44%)
USD |
NASDAQ |
Aug 24, 16:00
146.50
-0.26
(-0.18%)
After-Hours: 20:00
Gilead Sciences Shareholders Equity (Quarterly) : 11.83B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.83B |
| March 31, 2026 | 23.52B |
| December 31, 2025 | 22.70B |
| September 30, 2025 | 21.54B |
| June 30, 2025 | 19.67B |
| March 31, 2025 | 19.16B |
| December 31, 2024 | 19.33B |
| September 30, 2024 | 18.48B |
| June 30, 2024 | 18.28B |
| March 31, 2024 | 17.54B |
| December 31, 2023 | 22.83B |
| September 30, 2023 | 22.31B |
| June 30, 2023 | 21.16B |
| March 31, 2023 | 21.00B |
| December 31, 2022 | 21.24B |
| September 30, 2022 | 21.08B |
| June 30, 2022 | 20.24B |
| March 31, 2022 | 19.93B |
| December 31, 2021 | 21.07B |
| September 30, 2021 | 21.47B |
| June 30, 2021 | 19.70B |
| March 31, 2021 | 18.95B |
| December 31, 2020 | 18.20B |
| September 30, 2020 | 17.44B |
| June 30, 2020 | 18.03B |
| Date | Value |
|---|---|
| March 31, 2020 | 22.07B |
| December 31, 2019 | 22.52B |
| September 30, 2019 | 20.60B |
| June 30, 2019 | 22.62B |
| March 31, 2019 | 21.95B |
| December 31, 2018 | 21.39B |
| September 30, 2018 | 22.86B |
| June 30, 2018 | 21.67B |
| March 31, 2018 | 20.59B |
| December 31, 2017 | 20.44B |
| September 30, 2017 | 24.84B |
| June 30, 2017 | 22.68B |
| March 31, 2017 | 20.44B |
| December 31, 2016 | 18.89B |
| September 30, 2016 | 16.87B |
| June 30, 2016 | 15.54B |
| March 31, 2016 | 13.40B |
| December 31, 2015 | 18.53B |
| September 30, 2015 | 17.41B |
| June 30, 2015 | 16.29B |
| March 31, 2015 | 17.18B |
| December 31, 2014 | 15.43B |
| September 30, 2014 | 13.57B |
| June 30, 2014 | 16.09B |
| March 31, 2014 | 13.39B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 20.25B |
| AbbVie, Inc. | -5.935B |
| Regeneron Pharmaceuticals, Inc. | 31.71B |
| Amgen, Inc. | 11.69B |
| Biogen, Inc. | 18.85B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 49.36B |
| Total Liabilities (Quarterly) | 37.62B |
| Debt to Equity Ratio | 2.219 |
| Current Ratio | 1.266 |
| Net Debt Paydown Yield | -0.17% |